Dr. Monika Gulia-Nuss's research focuses on understanding the biology of ticks and the pathogens they transmit, such as those causing Lyme disease. The lab is developing advanced genetic techniques, particularly using CRISPR/Cas9, to create genetically modified ticks that can help scientists study how ticks transmit diseases. This work aims to improve tick control strategies and enhance our knowledge of tick biology at the molecular level, ultimately contributing to public health and agricultural advancement.